Colorectal Liver Metastasis Clinical Trial
Official title:
Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over Time
This study is being done to learn more about health related quality of life factors in people having surgery for colorectal liver metastasis. The investigators will look at how these factors may change over time. The information gained from this study will help the investigators to understand the long-term effects that cancer treatments have on the health related quality of life of patients. This information is of high value and will help doctors talk to patients about the possible effects of their operations. While many patients live a long time after such operations, the studies that have been done do not tell the full story of what patients go through after surgery. This study will help us to understand cancer treatment from the patient's perspective. It will also help cancer patients make better decisions about their treatment options and will help them know what to expect after the operation.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02642978 -
Robot-assisted Procedure Versus Open Simultaneous Resection of Colorectal Cancer With Liver Metastases
|
N/A | |
Active, not recruiting |
NCT04751773 -
Postoperative Exercise Training in Patients With Colorectal Liver Metastases Undergoing Surgery (ELMA)
|
N/A | |
Recruiting |
NCT03895723 -
Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases
|
N/A | |
Completed |
NCT01523353 -
Prehabilitation in Liver Surgery
|
Phase 1 | |
Recruiting |
NCT04678583 -
Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer
|
N/A | |
Completed |
NCT02727179 -
Open vs Laparoscopic Liver Surgery for Colorectal Liver Metastases
|
N/A | |
Recruiting |
NCT05753163 -
Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study
|
Phase 2 |